| 304.94 Delayed Data As of May 17 |  -3.10 / -1.01%Today’s Change | 291.10 Today|||52-Week Range 442.00 | -18.36% Year-to-Date |
| Previous close | 308.04 |
| Today’s open | 305.80 |
| Day’s range | 303.70 - 309.21 |
| Volume | 756,025 |
| Average volume (3 months) | 781,219 |
| Market cap | $32.9B |
| Earnings growth (last year) | +100.98% |
| Earnings growth (this year) | -5.78% |
| Earnings growth (next 5 years) | +11.17% |
| Revenue growth (last year) | +14.28% |
| P/E ratio | 14.4 |
| Price/Sales | 6.39 |
| Price/Book | 3.80 |
| Today’s change | Today’s % change | |
|---|---|---|
| ALXNAlexion Pharmaceutic... | -0.50 | -0.38% |
| BAXBaxter International... | -0.92 | -1.20% |
| VRTXVertex Pharmaceutica... | -1.50 | -0.88% |
| AGNAllergan | +0.16 | +0.11% |
| Next reporting date | August 5, 2019 |
| EPS forecast (this quarter) | $5.31 |
| Annual revenue (last year) | $6.7B |
| Annual profit (last year) | $2.4B |
| Net profit margin | 36.42% |
Sector Health Technology |
Industry Biotechnology |
Co-President, Chief Executive Officer & Director Leonard S. Schleifer |
Co-President, Director & Chief Scientific Officer George Damis Yancopoulos |
Corporate headquarters Tarrytown, New York |
